Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Pre-Eclampsia - Pipeline Insight, 2024
Pre-Eclampsia - Pipeline Insight, 2024 DelveInsight’s, “Pre-Eclampsia - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More
-
Schizophrenia - Pipeline Insight, 2024
Schizophrenia - Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More
-
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, there were an estimated 42 million prevalent cases of MASH in the 7MM. Out of these, a total of ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in t ... Read More
-
Type 2 Diabetes - Pipeline Insight, 2024
Type 2 Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Type 2 Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Type 2 Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
-
Lou Gehrig’s disease - Pipeline Insight, 2024
Lou Gehrig’s disease - Pipeline Insight, 2024 DelveInsight’s, “Lou Gehrig’s disease - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
-
Myotonic Dystrophy - Pipeline Insight, 2024
Myotonic Dystrophy - Pipeline Insight, 2024 DelveInsight’s, “Myotonic Dystrophy - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 27+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More
-
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 4 ... Read More
-
Smoking Cessation- Pipeline Insight, 2024
Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More
-
Lupus Nephritis - Pipeline Insight, 2024
Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 1,028,651 diagnosed prevalent cases of NCFB in the 7MM. Of these, the US accounted for approximately 37% of the cases, EU4 and the ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). This growth is primarily d ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting for approximately USD 12 billion which is further expected to rise at a CAGR of 2. ... Read More
-
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for ITP was estimated to be nearly USD 4,100 million in 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parainfluenza virus infection market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of parainfluenza virus infection in the 7MM is expected to ... Read More
-
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parkinson’s disease Psychosis (PDP) market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of PDP in the 7MM is expected to increase, driven by better ... Read More
-
Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030 Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, A ... Read More
-
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to the IgA Nephropathy Foundation, IgA nephropathy is an autoimmune disease that attacks the kidneys and affects blood filtration in the kidneys' small blood vessels. IgA nephropathy occurs when an abn ... Read More
-
Myotonic Dystrophy - Epidemiology Forecast - 2034
Myotonic Dystrophy - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysis indicates that there were nearly 54,068 diagnosed prevalent cases of myotonic dystrophy in the United States in 2023. Projections suggest that these cases will continue to rise, with anticipated growth reaching ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Down’s syndrome is a genetic condition caused by an error in cell division called ""nondisjunction,"" resulting in an individual having a full or partial extra copy of chromosome 2 ... Read More
-
Mild Cognitive Impairment - Epidemiology Forecast - 2034
Mild Cognitive Impairment - Epidemiology Forecast - 2034 Key Highlights In 2023, the total diagnosed prevalence of MCI in Parkinson’s disease was highest in Germany among the EU4 and the UK, accounting for nearly 995 thousand cases which is further expected to increase by 2034. In the US, in 2023, ~ ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 2,718 thousand diagnosed prevalent cases of Parkinson’s disease in the 7MM. Of these, the United States accounted for 45% of the cases, w ... Read More
-
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Diamond-Blackfan anemia (DBA) is a rare genetic disorder that primarily affects the bone marrow's ability to produce red blood cells, leading to severe anemia. It is usually diagnosed in infancy or ear ... Read More
-
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Mild Cognitive Impairment (MCI) was highest in the US among the 7MM, accounting for approximately USD 1,467 million which is further expected to increase by 2034. In 2023, ... Read More
-
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Osteogenesis Imperfecta (OI) is a group of genetic disorders that mainly affect the development of bones. People with this condition have bones that break easily, often from little or no tra ... Read More
Research Assistance
